Meto's clinical team has written a clear breakdown of pharmaceutical-grade versus research peptides that is worth reading before considering any peptide protocol
Quantitative data were obtained using ImageJ software
Unfortunately, GBM remains largely resistant to treatment and is associated with a poor prognosis, with an average survival of 15 months after diagnosis and less than 10% of patients surviving 5 years post-diagnosis (Ostrom et al., 2015)
Additional information Informed consent The authors affirm that human research participants provided informed consent for publication of the images in Figs
Supplement Facts: Serving Size: 1 Bar (60g) Servings Per Container: 12 Amount Per Serving: Energy kcal: 214 kcal Energy kJ: 896 kJ Fat: 13.2 g of which saturates: 4.2 g Carbohydrates: 13.5 g of which sugars: 1.4 g of which polyols: 10.6 g Fibre: 6.7 g Protein: 23.2 g Salt: 0.45 g *RI - Reference Intake Ingredients: MILK Protein, MILK Chocolate (Sweetener: Maltitol, Cocoa Butter, Whole Milk Powder, Cocoa Mass, Emulsifier (SOY Lecithin), Flavours) 18.3%, Gelatine Hydrolysate, Bulking Agent (Polydextrose), Humectant (Glycerol), SOY Crisps (SOY Protein, Tapioca Starch, Salt), SOY Crisp (SOY Protein, Fat Reduced Cocoa, Tapioca Starch), Cocoa Butter, SOY Oil, Skimmed MILK Powder, Palm Fat, Sweeteners (Xylitol, Sucralose), Flavours, Fat Reduced Cocoa, Salt, Emulsifier (SOY Lecithin)
Unfortunately, we are not able to provide a specific explanation for this response
